Orchestra BioMed Holdings, Inc. (OBIO)

5.08USD +7.17% (+0.34)

Over 6M: +8.8%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

4 5
Mar Apr May Jun Jul Aug Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 419K Q3 '23 — Operating Income: -14.5M Q4 '23 — Revenue: 262K Q4 '23 — Operating Income: -12.5M Q1 '24 — Revenue: 620K Q1 '24 — Operating Income: -14.4M Q2 '24 — Revenue: 778K Q2 '24 — Operating Income: -16.9M Q3 '24 — Revenue: 987K Q3 '24 — Operating Income: -16.3M Q4 '24 — Revenue: 253K Q4 '24 — Operating Income: -16.7M Q1 '25 — Revenue: 868K Q1 '25 — Operating Income: -18.9M Q2 '25 — Revenue: 836K Q2 '25 — Operating Income: -19.3M Q3 '25 — Revenue: 861K Q3 '25 — Operating Income: -20.3M Q4 '25 — Revenue: 30.9M Q4 '25 — Operating Income: 6.8M Q1 '26 — Revenue: 110K Q1 '26 — Operating Income: -22.1M Q2 '26 — Revenue: 88K Q2 '26 — Operating Income: -22.4M -15M 0 15M 30M 45M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 34.8%
OE margin -219.6%
Oper. margin -181.4%
Accruals -0.61%
Gross margin 99.5%
EBITDA margin -180.3%
FCF margin -184.8%
OCF margin -182.4%
Profit margin -184.6%
ROA -51.0%
ROCE -56.7%
ROE -305.5%
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

4.1
EV/Sales 6.3×
EV/OE -2.9×
P/C 2.7×
FCF yield -19.9%
P/B 15.3×
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.5
RPO / sales 0.34×
RPO growth -26.2%
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
Current ratio 12.6×
ND/EBITDA 0.47
Interest cover -40.1×
Cash / Debt 7.3×
Debt payback 0.0 yr
Quick ratio 8.2×
F-score 6.0 pts
Cash runway 1.6 yr
Debt / Eq 0.78×
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

10.0
Sales/sh Y/Y +737.4%
Sales Q/Q -89.5%
Shares change +29.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.